)P2] to fructose 6-phosphate (Fru6P) and Pi. Liver, muscle and brain Fru(1,6)Pase isoenzymes have been detected in mammalian tissues. The liver isoenzyme, recognized as a regulatory enzyme of gluconeogenesis [1] , has also been found in kidney and intestine [1] [2] [3] [4] . The physiological role of the muscle and brain isoenzymes is rather an enigma. Newsholme and Start postulated that the muscle isoenzyme participates in the regulation of glycolysis [5] . On the other hand, Mizunuma and Tashima [6] , on the basis of the kinetic properties of the mouse muscle isoenzyme, concluded that this enzyme is inactive in vivo in the presence of physiological inhibitors like AMP and fructose-2-6-bisphosphate (Fru(2,6)P2). A number ofpapers have been published concerning purification of liver Fru (1, 6) Pase from different species, structure/function relationship, primary structure, including that of the human liver enzyme, and determination of kinetic properties [7] [8] [9] [10] [11] [12] [13] [14] [15] . Much less information is available on the muscle isoenzyme [12, 16, 17] . No purification of human muscle Fru(1,6)Pase has been reported and little information on the kinetic properties of human muscle isoenzyme, determined as a homogenate, has been reported [18] .
This prompted us to focus our attention on the human muscle isoenzyme. In the present paper, a simple procedure for the isolation of human muscle Fru (1, 6) Pase is presented and the enzyme's kinetic properties are described. The application of the integrated method to kinetic investigation enabled relatively easy determination of the synergistic effects of AMP and Fru(2,6)P2 on the human muscle isoenzyme.
MATERIALS AND METHODS Materials
Tris, Bis-Tris-Propane (BTP), NADP, NADH, AMP, EDTA, MgCl2,6H20, /8-mercaptoethanol, acrylamide, bisacrylamide, isoenzymes, the human muscle enzyme is more strongly inhibited by AMP than is the liver isoenzyme [Dzugaj and Kochman (1980) 
Enzyme assays
Fru(1,6)Pase activity was measured as described by Traniello et al. [19] . The standard assay mixture (1 ml of the final volume) contained 50 mM BTP, 2 mM MgCl2, 150 mM KCI, 1 mM EDTA, 0.2 mM NADP+, 5 units/ml glucose-6-phosphate dehydrogenase, 5 units/ml glucose-6-phosphate isomerase, 40 ,uM Fru(1,6)P2, pH 7.5; the assay was carried out at 37 'C.
In order to determine Fru(1,6)Pase activity in conditions imitating the physiological state, 1 ml of the following assay mixture was used: 50 mM BTP/2 mM MgCl2/ 150 mM KCI/ 1 mM EDTA/0.2 mM NADP+/1 5 ,uM AMP/I,4M Fru(2,6)P2/ 5 units/ml glucose-6-phosphate dehydrogenase/5 units/ml glucose-6-phosphate isomerase/35 ,M Fru(1,6)P2/50 ,ug of Fru(1,6)Pase (approx. 1.4 ,tM catalytic sites) (pH 7.5); the assay was carried out at 37 'C.
Aldolase activity was measured in the presence of coupling enzymes, triose-3-phosphate isomerase and glycerol-3-phosphate dehydrogenase, after the decrease in absorbance of NADH. A standard mixture contained 50 mM BTP, 2 mM MgCl2, 150 mM KCl, 1 mM EDTA, 0.2 mM NADP+, 5 units/ml glycerol-3-phosphate dehydrogenase and 5 units/ml triose-3-phosphate isomerase, 40 ,uM Fru(1,6)P2, pH 7.5; the assay was carried out at 37 'C.
For determination of kinetic parameters 0.4,g/ml' Fru-(1,6)Pase was used. One unit of enzyme activity is defined as that [20] . All other parameters were calculated with the integrated method using the Matlab program of MathWorks [21] and TURBO-Pascal of Borland Inc. Fru(l ,6)Pase concentration was determined spectrophotometrically assuming that A1°m = 6.3 at 280 nm. During the purification procedure, protein concentration was measured as described by Lowry et al. [22] . Magnesium concentration was determined by titration of magnesium solution with EDTA in the presence of Eriochrome Black T. AMP concentration was determined spectrophotometrically by using 15400 M cm-' as the molar absorption coefficient at 259 nm. To determine Fru-(2,6)P2 concentration this compound was hydrolysed with HCI at pH 2 for 10 min. Released Pi was determined as described by Tashima and Yoshimura [23] . Fru6P was determined as described by Traniello et al. [19] .
Purification procedure A 10 g portion of the human skeletal muscle (m. pectoralis), removed surgically, was homogenized in 20 ml of 1 M saccharose/1 mM EDTA (pH 7.5) for 3 min, and the homogenate was centrifuged at 13000 g for 15 min. The supernatant was filtered through glass wool and rapidly heated at 68°C for 3 min in a water bath with stirring. Then it was rapidly cooled and centrifuged at 13 000 g for 15 min. To remove aldolase, (NH4)2SO4 was slowly added until 65 % saturation was reached. After 15 h the pellet was removed and the supernatant was dialysed overnight against 1 mM EDTA, pH 7.0. The dialysate was diluted in 2.5 vol. of 1 M saccharose/1 mM EDTA (pH 7.5) and was treated with moist phosphocellulose (1 g per 10 ml of solution). The enzyme was adsorbed at pH 8.0. After 1 h the suspension was loaded on to a Pharmacia K 16/40 column. The phosphocellulose was washed with 50 mM Tris/0.5 mM EDTA (pH 7.5) until the absorbance at 280 nm of the eluate had fallen below 0.01. Fru(1,6)Pase was eluted with the same buffer containing 3 mM Fru(1,6)P2 and 3 mM AMP. Fractions containing Fru(1,6)Pase were pooled and dialysed against 50 mM Tris/0.5 EDTA (pH 7.5).
SDS/PAGE of purified Fru(1,6)Pase was performed as described by Weber and Osborn [24] . A sample (1 ,ug) of the protein was applied on the top of the gel. Polyacrylamide-gel disc electrophoresis showed only one sharp protein band. 
We will obtain the same expression for non-competitive inhibition under rapid equilibrium conditions when K14 > K.
On the basis of the recorded progress of the reaction, the parameters for two considered possibilities were calculated. In the first case Vms,, Km and [S]J and in the second Vmax, Km, K,, and [SO], were determined. All parameters were calculated for five curves. The increase of absorbance was read at even intervals of 1 s. Calculations were performed using non-linear regression. The details of all calculations are in the appendix.
Taking into consideration the inhibition of Fru (1, The standard assay mixture was as described in the Materials and methods section; various concentrations of free magnesium were used. The inset shows the Hill plot of the data.
inhibition by the substrate is observed. The inhibition by the substrate is presented in Figure 2 . Figure 5 . Ka was calculated to be 233 uM, and h = 2.0.
Activity of Fru(1,6)Pase under close-to-physiological conditions
In vivo the Fru(1,6)Pase concentration is much higher than that used in a cuvette for the determination of kinetic properties. To determine Fru(1 ,6)Pase activity under close-to-physiological conditions, the experiment was performed using concentrations of Fru(1,6)Pase, substrate and inhibitors comparable with those in the muscle cell. The enzyme was inhibited by 99.9%.
DISCUSSION
The mammalian muscle Fru(1,6)Pase as compared with the liver isoenzyme is more sensitive to inhibition by AMP. I0.5 iS 10-60 times lower for the muscle than for the liver enzyme [7, 12, 14, 16, 29] . Other kinetic properties are of the same range. The reported differences are mainly due to different assay conditions (the temperature and the presence or absence of chelating agents and univalent cations) [7, 12, 23, 29] . Human muscle Fru(1,6)Pase is synergistically inhibited by AMP and Fru(2,6)P2. This interesting phenomenon was first observed for the mammalian liver isoenzyme [30] as well as for mouse muscle Fru(1,6)Pase [29] . Bosca et al., working on partially purified rabbit and rat muscle Fru(1,6)Pase, did not find the synergistic effect of AMP and Fru(2,6)P2 on the two proteins [17] . Those enzymes were partially proteolysed, since the ratio of activity at pH 9.3 to activity at pH 7.5 was 0.67 for rabbit and 0.71 for rat Fru(1,6)Pase. That value for native Fru(1,6)Pase should not exceed 0.4 [31] . Proteolytic modification of Fru(1,6)Pase results in desensitization to AMP [31] and Fru(2,6)P2 [32] inhibition and it might be the cause of the lack of synergism. The inhibition of mammalian liver Fru(1,6)Pase by excess substrate was reported [12, [25] [26] [27] [28] . A similar phenomenon was observed in the case of the human muscle enzyme. The inhibition of Fru(1,6)Pase by a substrate raises a question concerning determination of Km. Usually this problem has been neglected and Km has been calculated without taking into account inhibition by substrate. Assuming the allosteric character of substrate binding to the catalytic site as well as to inhibitory sites, Vargas et al. [28] calculated the corresponding binding constant. They found that the binding constant of substrate to the rat kidney Fru(1,6)Pase catalytic site is approx. 100 times higher than the binding constant of substrate to inhibitory site [28] . Investigating the effect of temperature on kinetic properties of human and rabbit liver Fru(1,6)Pase, we have found slight co-operativity in the binding of substrate to Fru(1,6)Pase at 25°C, which disappeared at 37°C [7] . All determination of the human muscle enzyme kinetic properties were performed at the physiological temperature. Therefore we considered the non-allosteric type of inhibition. There are two possibilities: uncompetitive or noncompetitive type of inhibition. As we have shown in the Materials and methods section, those two models under rapid equilibrium conditions when K,, > K. are not kinetically distinguishable. Liu and Fromm [33] suggested that the site of binding of Fru(2,6)P2 to Fru(1,6)Pase partially overlaps the catalytic site. It might be the same site to which the second substrate molecule binds; in this case the inhibition by substrate would be uncompetitive. The catalytic site of Fru(1,6)Pase has been determined [34] but the the binding constant of the substrate to the active site is much higher than that for the inhibitory site, at low concentrations of the substrate the inhibition of Fru(1,6)Pase is not perceptible. On the other hand it is necessary to take it into account when the integrated method of kinetic parameters determination is employed.
The basic question concerning muscle Fru(1,6)Pase is its physiological role. It seems that muscle Fru (1, 6) All measured points used for AO in the calculation corresponded to this concentration of substrate, which was much higher than Km, and the linear least-squares method could be used. To find the optimal values of V'ax, Km, k' and Amax. the non-linear least-squares method was applied. The sum of the squares of the residuals was minimized using the Nelder-Mead simplex algorithm [21, 42] . For optimization it was necessary to disentangle eqn. (A2) from the A value. Since analytically this is not possible, the numerical procedure to find the zero of a function was applied. For the successive values Vm max Km, k' and Ama., established by the optimization procedure, the theoretical value of absorbance (Ai,theor.) at each time t, was calculated: Ai,theor. = f(t,) i = 1, 2,..., n where n = number of measuring points.
These values were used to calculate the mean squared error of 
